New study to prevent type 1 diabetes with the Diamyd® diabetes vaccine approved by the Swedish Medical Products Agency on World Diabetes Day

Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) informs that today, on World Diabetes Day, the Swedish Medical Products Agency approved the planned new investigator initiated study with the Diamyd® diabetes vaccine in 80 children at high risk of presenting with type 1 diabetes. The aim is to test whether the diabetes vaccine can prevent or delay the onset of type 1 diabetes in the children.Type 1 diabetes starts long before the appearance of any clinical symptoms of the disease. The most recent research concludes that there are two early stages of type 1 diabetes, prior to